Shenzhen Efung Investment Management Co. Ltd.,(abbreviated as “Efung” or “Efung Capital”) is one of Shenzhen's earliest professional venture capital firms and has been rated as“The Top Ten Venture Capital Institutions in Shenzhen” for many years. Over the years, Efung Capital has focused on healthcare industries—especially VC and PE investments in innovative drugs and high-end medical devices. The company aims to promote the pharmaceutical industry with capital and bring investors rich returns. Efung Capital has carefully selected and invested more than 20 domestic and overseas high-quality enterprises such as ChipScreen, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals and Centrexion Therapeutics. At the same time, Efung has also created a platform that attracts excellent talents from the industry. Through this platform, Efung helps its portfolio companies establishing enterprise system, seeking strategic partners, designing plans for their future financing rounds and development. In an era that biotechnologies is changing the world, Efung capital is dedicated to promoting the pharmaceutical and medical technology industry and has created enormous social influence. Through years of investment, Efung Capital formed a concept that "Investment is service". With an experienced and professional management team, Efung is dedicated to becoming an entrepreneur-oriented, trust worthy and long-lasting venture.